RE: TOP UP BEFORE RESULTS13 May 2020 12:41
nice steady buying
how many buyers are using this low share price to load up for the amount of news due at ncyt
over next two months
that's my reason for buying more
Research and development update
As announced on 15 April 2020, Novacyt has been working to address the current reported global shortfall in extraction reagents required to perform PCR testing through the development of a new extraction technology. This technology avoids the use of magnetic beads commonly used in the extraction process. The development of a new "direct-to-PCR" extraction method, Exsig™ Free, used prior to running the Company's COVID-19 test, will therefore remove the need for scarce reagents used with magnetic beads and significantly reduces the number of extraction steps, allowing faster cycle times, higher throughputs and cost savings. The Directors believe this innovation should facilitate an increase in testing capacity for COVID-19, removing a current bottleneck in sample processing for laboratories. Development is progressing well and Novacyt is on track to launch this new extraction technology in May 2020.
this in June
Manufacturing capacity
On 15 April 2020, Novacyt announced plans to increase manufacturing capacity to approximately eight million tests per month. The Company is on track with this scale-up and expects to achieve at least this level of output during June 2020. In addition, Novacyt has signed manufacturing partnership agreements with two further contract manufacturers based in the UK. This provides Novacyt with a total of six sub-contract manufacturers in addition to its own manufacturing sites in Southampton and Camberley, which provides greater contingency and the flexibility to scale-up its manufacturing outputs beyond eight million tests per month when necessary.
also more sales updates
Sign In
Follow the stocks
